B. Visy

发表

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

A. Tordai, L. Truedsson, M. López-Trascasa, 2004, Journal of Allergy and Clinical Immunology.

[Analysis of the relationship between vitamin D3 level and disease severity in hereditary angioedema].

H. Farkas, É. Imreh, L. Varga, 2019, Orvosi hetilap.

Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE).

Z. Rónai, H. Farkas, Z. Prohászka, 2007, Molecular immunology.

Association of celiac disease and hereditary angioneurotic edema

A. Tordai, L. Kalmár, H. Farkas, 2002, American Journal of Gastroenterology.

Management of Hereditary Angioedema in Pediatric Patients

H. Farkas, G. Szeplaki, L. Varga, 2007, Pediatrics.

Clinical management of hereditary angio‐oedema in children

H. Farkas, G. Füst, L. Varga, 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.

H. Farkas, G. Füst, L. Cervenak, 2007, Molecular immunology.

Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

H. Farkas, G. Füst, L. Jakab, 2007, The Journal of allergy and clinical immunology.

The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey.

H. Farkas, G. Füst, F. Tóth, 2010, European journal of obstetrics, gynecology, and reproductive biology.

Diagnosing Pediatric Patients With Hereditary C1-Inhibitor Deficiency—Experience From the Hungarian Angioedema Center of Reference and Excellence

Á. Szilágyi, H. Farkas, D. Csuka, 2022, Frontiers in Allergy.

Clinical characteristics and safety of plasma-derived C1-inhibitor therapy in children and adolescents with hereditary angioedema - a long-term survey.

H. Farkas, L. Varga, N. Veszeli, 2020, The journal of allergy and clinical immunology. In practice.

The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study

H. Farkas, Z. Prohászka, G. Füst, 2010, European Journal of Clinical Pharmacology.

Sex hormones in hereditary angioneurotic oedema

H. Farkas, G. Füst, E. Takács, 2004, Clinical endocrinology.

Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema.

H. Farkas, G. Füst, G. Szeplaki, 2010, Clinical immunology.

Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema.

H. Farkas, G. Füst, C. Bucher, 2007, Helicobacter.

Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema.

H. Farkas, I. Karádi, L. Varga, 2001, Acta dermato-venereologica.

Acute abdominal attack of hereditary angioneurotic oedema associated with ultrasound abnormalities suggestive of acute hepatitis

H. Farkas, I. Karádi, L. Varga, 2002, Acta paediatrica.

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency

H. Farkas, D. Csuka, L. Varga, 2021, Clinical and translational allergy.

Abdominal symptoms of hereditary angioedema and early weaning

H. Farkas, G. Füst, D. Csuka, 2010, European Journal of Clinical Nutrition.

Helicobacter pylori Infection as a Triggering Factor of Attacks in Patients with Hereditary Angioedema

H. Farkas, G. Füst, C. Bucher, 2007 .

Association of celiac disease and hereditary angioneurotic edema.

A. Tordai, L. Kalmár, H. Farkas, 2002 .

Pericardiac effusion complicating an acute abdominal attack of hereditary angioneurotic edema

H. Farkas, P. Altorjai, F. Fekete, 2008 .